WebOct 1, 2024 · Bullnet Capital impulsa el desarrollo de Bioherent. El venture capital invertirá dos millones de euros para posicionar a esta nueva empresa, surgida en Málaga, como referente en el desarrollo de dispositivos para el diagnóstico de la alergia a fármacos, según ha informado la Junta de Andalucía a través de un comunicado.. Un grupo de … WebOct 7, 2024 · Málaga. La empresa de base tecnológica ‘Bioherent’, ha desarrollado un primer prototipo de diagnóstico clínico in vitro para las alergias a antibióticos basado en un biosensor fotónico ...
Bioherent LinkedIn
WebBioherent General Information. Description. Developer of photonic biosensors for the diagnosis of drug allergies intended to revolutionize drug allergy tests. The company develops sensitive, in-vitro, low-cost medical diagnostic structures, helping healthcare professionals to diagnose and treat allergic diseases more efficiently. WebAug 10, 2024 · Bioherent was founded one year ago to advance development of its laboratory prototype that uses ultra-sensitive photonic biosensors for the rapid and accurate detection of drug allergies, such as beta-lactam antibiotics. Having developed a rapid, reliable, in-vitro, low-cost diagnostic device that could successfully address these issues, … incompass software
How to take Sinupret - instructions for use (2024)
WebIn the last years, photonics is gaining a key enabling technology in space engineering. Optical, opto-electronic, and photonic payloads are currently widely utilized especially for earth observation, sensing and several new payloads based on the same technologies are in the development stage. WebInherent Biosciences is a biotechnology company pioneering epigenetic medicine for complex diseases. The company’s epigenetic platform detects dysregulation across … WebJ. Gonzalo Wangüemert-Pérez was born in Canary Islands, Spain. He received the M.Sc. degree in telecommunications engineering from the Polytechnic University of Madrid, … incompass racing